What Exocel Bio does

Exocel Bio is a privately held biotechnology company that designs and manufactures mesenchymal stem cell (MSC)-derived exosome products for professional regenerative aesthetics. The company operates under cGMP and ISO standards at a state-of-the-art GMP cleanroom facility located at the Pennsylvania Biotechnology Center in Doylestown, and sells exclusively to licensed clinicians rather than consumers. Its core brand, exovex, spans exovex Skin (5B, 12B, 25B exosome concentrations), exovex+ Skin (5 Trillion EVs with a multi-component bioactive complex), and exovex+ Hair (7B, 15B, 30B concentrations), plus research-grade exosomes (75B, 100B, 450B) and a custom concentration service for academic and biotech researchers.

The company's technical differentiation rests on a proprietary 9-step manufacturing process, tangential flow filtration for large-scale GMP-compatible isolation, and third-party validation using ExoView chip assays, mass spectrometry, NGS, PCR, MudPIT, and NTA to verify exosome identity (CD9, CD63, CD81 markers), purity, and potency. Research claims include over 500 specific growth factors and biomolecular cargo including mRNA, miRNA, collagen, keratin, and Wnt-pathway proteins. The company is exploring novel enhancements such as simulated microgravity and hypoxic culture conditions, presented at the SELECTBIO Space Summit 2025.

Exocel Bio generates revenue through one-time purchases of professional exosome serums and research-grade exosomes sold direct to clinics, medical spas, hair restoration practices, and academic institutions via a contact-based, quote-driven sales model. Distribution is domestic US only, supported by monthly Exovex Experiences webinars, Peer-to-Peer Physician Forums, and active participation in aesthetic and extracellular vesicle industry conferences. Scientific advisory board members from Harvard Medical School, Mount Sinai, and other leading institutions lend clinical and translational credibility to the offering.

Name

Exocel Bio

Legal name

Exocel Bio

Website

https://exocelbio.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Regenerative Aesthetics Biologics

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industries

Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Professional/Backbar Skincare (Esthetician & Spa Use) (CRABAAAK)

Keywords

• Exosome skincare
• Regenerative aesthetics
• MSC-derived exosomes
• Professional aesthetic biologics
• Hair restoration serums

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Professional Exosome Products: Sale of exovex branded exosome serums and solutions to licensed aesthetic clinics and medical professionals. Products include exovex Skin (5B, 12B, 25B concentrations) and exovex+ Hair (7B, 15B, 30B concentrations) and exovex+ Skin (5 Trillion EVs). Professional-use only, sold directly to practices.
2. Custom Concentration Exosomes: Research-use exosomes at custom concentrations for academic and biotech research institutions. Products made to order with 3-4 week lead time, targeting specific concentration requirements for research or therapeutic applications.
3. Research Exosome Products: Sale of bulk research-grade exosomes (75B, 100B, 450B concentrations) for research-only applications. Purified active exosomes suspended in medical-grade saline, free of additives and chemicals.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Core offering

Exocel Bio designs, manufactures, and sells exovex-branded MSC-derived exosome serums and solutions for professional skin rejuvenation and hair restoration, along with research-grade exosome products for academic and biotech use. All products are manufactured under cGMP and ISO standards at the Pennsylvania Biotechnology Center and are sold exclusively to licensed medical professionals and verified research institutions, not directly to consumers.

Product overview

Exocel Bio offers a unified portfolio of exosome-based regenerative products centered on its exovex® brand. The core offering includes exovex® Skin (available in 5B, 12B, and 25B concentrations) and exovex+ Skin (5 Trillion EVs with enhanced peptide complex) for skin rejuvenation, and exovex+ Hair (7B, 15B, 30B) for hair restoration. Supporting the professional product line are research-grade exosomes in 75B, 100B, and 450B concentrations, plus a custom concentration service for researchers. All products derive from MSC-derived exosomes and are intended exclusively for professional use.

Differentiator

Problem solved

Functional benefit

Brands

• exovex+ SKIN: Professional-use exosome serum for skin rejuvenation, delivering 5 trillion extracellular vesicles with pure active intact exosomes, methylcobalamin, bioactive peptides, cytokines and growth factors.
• exovex® SKIN
• exovex+ HAIR

Products and services

• exovex Skin Professional-use exosome serum designed to support visibly revitalized, healthier-looking skin through advanced cellular science. Powered by purified MSC-derived exosome-rich components, growth factors, and mRNA elements. Available in three concentrations: 5 Billion, 12 Billion, and 25 Billion exosomes per vial. For professional use only by licensed practitioners.
• exovex+ Skin Advanced professional skin rejuvenation serum delivering 5 Trillion Extracellular Vesicles with six bioactive components including Pure Active Intact Exosomes, Methylcobalamin (Vitamin B12), Bioactive Peptides, Cytokines, and Growth Factors in a 5ML professional serum. Manufactured under GMP standards with sterility and endotoxin testing and full manufacturing traceability in a GMP-certified facility in the USA. For professional use only.
• exovex+ Hair Professional hair treatment formulation with multi-factor complex including selected microRNAs (miR-10a, miR-21-5p, miR-26a-5p, miR-31, miR-146a-5p, miR-218-5p), peptides, vitamins, growth factors (FGF1/2/7/10, IGF-1/2, VEGFA, PDGF-A/B), cytokines, and Wnt pathway proteins. Available in 7 Billion, 15 Billion, and 30 Billion concentrations. For professional use only.
• Research Exosomes (For Research Only) Highly concentrated, purified active exosomes suspended in medical-grade saline for research purposes. Free of additives and chemicals, available in 75 Billion, 100 Billion, and 450 Billion concentrations in 5ml vials, containing 500+ specific growth factors along with mRNA, miRNA, and proteins including collagen, keratin, elastin, and fibulin. For research use only.
• Custom Concentration Exosomes Custom concentration exosome service for research applications, allowing researchers and biotech institutions to specify exact concentration requirements tailored to their research or therapeutic applications. Made-to-order with 3-4 week lead time.

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• University of PennsylvaniacoreStrategic or Co-development PartnerRenowned third-party collaborator and testing partner. Collaborates on scientific research and validation of exosome technology applications in regenerative medicine.
• Blumberg InstitutecoreStrategic or Co-development PartnerCollaborating institution located at Pennsylvania Biotechnology Center. Provides research infrastructure and institutional partnership for exosome development. Dr. Aejaz Sayeed established institutional partnership between Blumberg Institute and Capital Health Hospital.
• Rutgers UniversitycoreStrategic or Co-development PartnerRenowned academic collaborator contributing to scientific foundation of company's R&D efforts in exosome research.
• UCLAcoreStrategic or Co-development PartnerAcademic research partner contributing to company's scientific research and development initiatives in regenerative medicine.
• University of TorontocoreStrategic or Co-development PartnerInternational academic collaborator contributing to scientific foundation and ongoing research and development efforts.
• Washington UniversitycoreStrategic or Co-development PartnerSelected as finalist in global pitch competition hosted in collaboration with WashU, recognizing innovative biotech solutions. Presentation addressed blood-brain barrier challenges and novel exosome-based approach for epilepsy treatment.
• SELECTBIOminorGTM or Marketing PartnerConference organizer for The Space Summit 2025 and Extracellular Vesicles & Lipid Nanoparticles tracks. Platform for presenting research on space microgravity and hypoxia conditions for MSC-derived exosome enhancement.
• Exodus SymposiumminorGTM or Marketing PartnerIndustry symposium on extracellular vesicles R&D. Natalia Tumidajski joined panel discussion on emerging technologies and bridging scientific innovation with scalable GMP manufacturing.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• AbbVie (Allergan Aesthetics): Global aesthetics leader (Botox, SkinMedica, CoolSculpting) with massive professional channel reach. Represents the broad incumbent benchmark that Exocel Bio's professional aesthetic clinic customers already transact with daily.
• Galderma: Global dermatology and aesthetics leader (Sculptra, Restylane, Dysport) competing in medical aesthetics. Comparable as the broad incumbent targeting dermatologists and aesthetic clinics; Exocel Bio is a niche add-on to Galderma's regenerative-adjacent portfolio.
• Merz Aesthetics: Global medical aesthetics company (Xeomin, Radiesse, Ultherapy) with strong dermatology channel presence. Comparable broad incumbent serving the same medical spas and aesthetic practices that Exocel Bio targets.

Direct peers

• BENEV: US aesthetics and regenerative medicine company distributing exosome-based professional skincare lines. Comparable product portfolio, distribution model (B2B professional channel), and concentration-tier approach to exovex Skin/Hair.
• ExoCoBio: Korea-based pioneer in stem cell-derived exosome cosmetics and therapeutics with established US distribution. Directly comparable as an MSC-derived exosome company targeting the same aesthetic dermatology channel with overlapping scientific claims and SKUs.
• Rion Aesthetics: US-based aesthetics company commercializing placental-derived exosome products for skin rejuvenation and hair restoration. Closest direct competitor with overlapping product positioning, channel (aesthetic practices), and regenerative-biology messaging.
• Kimera Labs: US-based exosome company offering MSC-derived exosome products for aesthetics, sports medicine, and wellness. Direct competitor with overlapping core technology (MSC exosomes), manufacturing claims, and practitioner-focused distribution.

Emerging players

• Direct Biologics: US-based regenerative medicine company developing MSC-derived biologic products for wound care and orthopedic indications. Comparable emerging player in the broader exosome/MSC regenerative-medicine category Exocel Bio aspires to enter beyond aesthetics.
• Evoq Health: Emerging exosome therapeutics and skincare brand focused on professional regenerative applications. Comparable in category and customer base, but smaller scale and narrower product line than Exocel Bio.

Others

• Organogenesis: Regenerative medicine company (Apligraf, Dermagraft, NuShield) selling wound healing and surgical biologics. Comparable as an adjacent regenerative-medicine player whose wound-care franchise overlaps with Exocel Bio's emerging wound-healing use case (e.g., Palomar Health).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@exocelbio
• Instagraminstagram.com/exocelbio

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Exocel Bio